The opaque and loosely administered nature of the Medicare 340B drug-pricing program has lead to speculation over the appropriate use of program savings. Originally designed as a way to help patients save money on their prescription drugs, the 340B program is now criticized for failing to deliver those savings directly to consumer medications. Furthermore, a … Continue reading
America has a drug problem that goes well beyond opiates and abuse. Pharmaceutical drug prices have skyrocketed in the last decade and fueled an overall increase in health care costs and spending[1]. The top ten most prescribed medications have all risen more than 50% since 2011, with four out of ten having doubled in cost. … Continue reading
How a Holistic Approach to Pain Management can Solve the Nation’s Opioid Epidemic In 2017 drug overdoses became the leading cause of death for Americans less than 50 years old (Reynolds, 2017). Fueling this statistic is the opioid epidemic, which is responsible for 63% of all drug overdoses in the … Continue reading
Policy Interns 
You must be logged in to post a comment.